Full length articleBiomimetic contact lenses eluting Olopatadine (cas 113806-05-6) for allergic conjunctivitis☆

Add time:08/25/2019    Source:sciencedirect.com

Combination of the ability of contact lenses (CLs) to act as a physical barrier against airborne antigen and to serve as a sustained depot of antihistaminic drugs may improve the efficiency of treatments of some ocular allergic diseases. The aim of this work was to develop CLs that exhibit affinity to Olopatadine (cas 113806-05-6) by mimicking the composition of the natural H1-receptor for which olopatadine behaves as a selective antagonist. Functional monomers that match the chemical groups of the receptor and application of the molecular imprinting technology led to hydrogels able to load high amounts of olopatadine and to sustain the release once in contact with lachrymal fluid. Optimized hydrogels prepared with acrylic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid and benzylmethacrylate as functional monomers provided in few hours olopatadine concentrations similar to those of commercially available eye drops but the levels could be sustained for a whole day, demonstrating their efficacy. Olopatadine-loaded CLs successfully passed the HET-CAM test of ocular irritancy and showed good compatibility with mast cells. They were able to inhibit the release of histamine and TNF-α from sensitized mast cells, proving their potential application in preventing and treating allergic conjunctivitis.

We also recommend Trading Suppliers and Manufacturers of Olopatadine (cas 113806-05-6). Pls Click Website Link as below: cas 113806-05-6 suppliers

Prev:Olopatadine (cas 113806-05-6) enhances recovery of alkali-induced corneal injury in rats
Next:Olopatadine (cas 113806-05-6) hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation)